Form 4 for BMRA BIOMERICA INC
Accepted 2026-08-27 17:23:56 ET · period of report 2026-08-26 · accession 0001493152-26-040443 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 17:23 | 2026-08-26 | BMRA | Irani Zackary S. | CEO, Dir | P - Purchase | $1.60 | +31.2K | 242.6K | +15% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2026-08-26 | P | A | 31,250 | $1.60 | 242,570 | D | — | — | (F1) On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. |